Deadline for Expressions of Interest 31 March 2017
The new scheme
We are Breast Cancer Now, the UK’s leading breast cancer research charity. We believe research is what will ultimately give women with breast cancer more time to live. Our ambition: by the year 2050, everyone who develops breast cancer will live.
In order to get ahead of this complex disease, we need to change how we work. The big discoveries and the blockbuster drugs aren’t how we’ll move forward. It will be the incremental discoveries applied in different ways that will lead to truly targeted treatments. It will involve the academic research sector, pharmaceutical industry and charities like Breast Cancer Now working together.
To drive this, we have launched a new funding initiative called the Breast Cancer Now Catalyst Programme. This will bring together Europe’s leading breast cancer researchers and the world’s leading pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050.
The first partnership we’ve made is with Pfizer. Together we will provide exciting opportunities for breast cancer researchers across Europe.
As well as providing substantial funding for research grants, Pfizer are providing access to a number of its licensed and investigational drugs that may be useful for treating breast cancer.
Breast Cancer Now will use its peer review process to decide which research projects will be supported and will have access to Pfizer’s drugs. Pfizer will not be involved in making the decisions about which projects are funded.